BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 14526170)

  • 1. WWOX, the common chromosomal fragile site, FRA16D, cancer gene.
    Ludes-Meyers JH; Bednarek AK; Popescu NC; Bedford M; Aldaz CM
    Cytogenet Genome Res; 2003; 100(1-4):101-10. PubMed ID: 14526170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. WWOX, a novel WW domain-containing protein mapping to human chromosome 16q23.3-24.1, a region frequently affected in breast cancer.
    Bednarek AK; Laflin KJ; Daniel RL; Liao Q; Hawkins KA; Aldaz CM
    Cancer Res; 2000 Apr; 60(8):2140-5. PubMed ID: 10786676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.
    Bednarek AK; Keck-Waggoner CL; Daniel RL; Laflin KJ; Bergsagel PL; Kiguchi K; Brenner AJ; Aldaz CM
    Cancer Res; 2001 Nov; 61(22):8068-73. PubMed ID: 11719429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative transcripts of the candidate tumor suppressor gene, WWOX, are expressed at high levels in human breast tumors.
    Driouch K; Prydz H; Monese R; Johansen H; Lidereau R; Frengen E
    Oncogene; 2002 Mar; 21(12):1832-40. PubMed ID: 11896615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WWOX, a chromosomal fragile site gene and its role in cancer.
    Ramos D; Aldaz CM
    Adv Exp Med Biol; 2006; 587():149-59. PubMed ID: 17163164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells.
    Ried K; Finnis M; Hobson L; Mangelsdorf M; Dayan S; Nancarrow JK; Woollatt E; Kremmidiotis G; Gardner A; Venter D; Baker E; Richards RI
    Hum Mol Genet; 2000 Jul; 9(11):1651-63. PubMed ID: 10861292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WWOX binds the specific proline-rich ligand PPXY: identification of candidate interacting proteins.
    Ludes-Meyers JH; Kil H; Bednarek AK; Drake J; Bedford MT; Aldaz CM
    Oncogene; 2004 Jun; 23(29):5049-55. PubMed ID: 15064722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WWOX, the chromosomal fragile site FRA16D spanning gene: its role in metabolism and contribution to cancer.
    Richards RI; Choo A; Lee CS; Dayan S; O'Keefe L
    Exp Biol Med (Maywood); 2015 Mar; 240(3):338-44. PubMed ID: 25595186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel approach to simultaneously scan genes at fragile sites.
    Willem P; Brown J; Schouten J
    BMC Cancer; 2006 Aug; 6():205. PubMed ID: 16895604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma.
    Kuroki T; Trapasso F; Shiraishi T; Alder H; Mimori K; Mori M; Croce CM
    Cancer Res; 2002 Apr; 62(8):2258-60. PubMed ID: 11956080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent downregulation and loss of WWOX gene expression in human hepatocellular carcinoma.
    Park SW; Ludes-Meyers J; Zimonjic DB; Durkin ME; Popescu NC; Aldaz CM
    Br J Cancer; 2004 Aug; 91(4):753-9. PubMed ID: 15266310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WWOX: a fragile tumor suppressor.
    Schrock MS; Huebner K
    Exp Biol Med (Maywood); 2015 Mar; 240(3):296-304. PubMed ID: 25538133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WWOX, the FRA16D gene: A target of and a contributor to genomic instability.
    Hussain T; Liu B; Shrock MS; Williams T; Aldaz CM
    Genes Chromosomes Cancer; 2019 May; 58(5):324-338. PubMed ID: 30350478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer.
    Yendamuri S; Kuroki T; Trapasso F; Henry AC; Dumon KR; Huebner K; Williams NN; Kaiser LR; Croce CM
    Cancer Res; 2003 Feb; 63(4):878-81. PubMed ID: 12591741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common Chromosomal Fragile Site Gene WWOX in Metabolic Disorders and Tumors.
    Li J; Liu J; Ren Y; Yang J; Liu P
    Int J Biol Sci; 2014; 10(2):142-8. PubMed ID: 24520212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common chromosomal fragile site FRA16D mutation in cancer cells.
    Finnis M; Dayan S; Hobson L; Chenevix-Trench G; Friend K; Ried K; Venter D; Woollatt E; Baker E; Richards RI
    Hum Mol Genet; 2005 May; 14(10):1341-9. PubMed ID: 15814586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common chromosomal fragile sites and cancer: focus on FRA16D.
    O'Keefe LV; Richards RI
    Cancer Lett; 2006 Jan; 232(1):37-47. PubMed ID: 16242840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
    Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
    Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis.
    Kuroki T; Yendamuri S; Trapasso F; Matsuyama A; Aqeilan RI; Alder H; Rattan S; Cesari R; Nolli ML; Williams NN; Mori M; Kanematsu T; Croce CM
    Clin Cancer Res; 2004 Apr; 10(7):2459-65. PubMed ID: 15073125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fragile genes FHIT and WWOX are inactivated coordinately in invasive breast carcinoma.
    Guler G; Uner A; Guler N; Han SY; Iliopoulos D; Hauck WW; McCue P; Huebner K
    Cancer; 2004 Apr; 100(8):1605-14. PubMed ID: 15073846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.